IART — INTEGRA LIFESCIENCES HOLDINGS CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 917520 ·
Last close
$13.55
Market Cap
$1.05B
52W High
$20.49
52W Low
$8.70
ADV30
1,191,062
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 418,761,000 | 219,744,000 | 19,285,000 | 4,482,000 | 3,563,490,000 | 214,415,000 | 2,520,113,000 |
| Mar 2026 | 391,918,000 | 216,982,000 | 11,470,000 | -4,617,000 | 3,577,726,000 | 236,809,000 | 2,535,320,000 |
| Dec 2025 | 434,925,000 | 220,865,000 | 23,040,000 | -1,704,000 | 3,602,001,000 | 235,048,000 | 2,558,538,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$85,327,000
Investing CF
$-108,626,000
Financing CF
$21,576,000
CapEx
$-73,727,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.09
As of
2026-10-25
Balance + Analyst (yfinance extras)
Retained Earnings
$423,306,000
Inventory
$492,005,000
Receivables
$267,188,000
ST Investments
$59,669,000
EBIT TTM
$91,678,000
Pretax Income TTM
$-179,000
Interest Exp TTM
$91,857,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,656,786,048
EBITDA
$333,417,984
Free Cash Flow
$116,033,128
Enterprise Value
$2,617,931,520
Total Cash
$311,929,984
Total Debt
$2,003,251,968
Shares Out
77,772,506
Trailing EPS
$0.17
Book Value
$13.71
ROE
1.2%
ROA
3.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,635,245,000 | 17,995,000 | -516,474,000 | 3,602,001,000 | 2,558,538,000 | 1,043,463,000 | 50,384,000 |
| Dec 2024 | 1,610,527,000 | 28,411,000 | -6,944,000 | 4,037,424,000 | 2,492,144,000 | 1,545,280,000 | 129,382,000 |
| Dec 2023 | 1,541,573,000 | 111,526,000 | 67,741,000 | 3,781,988,000 | 2,194,104,000 | 1,587,884,000 | 139,955,000 |
| Dec 2022 | 1,557,666,000 | 238,920,000 | 180,550,000 | 3,889,758,000 | 2,085,355,000 | 1,804,403,000 | 264,469,000 |
TTM Snapshot
Revenues TTM
$1,647,666,000
NetIncome TTM
$-7,243,000
OpCashFlow TTM
—
Assets (Latest)
$3,563,490,000
Forward EPS
$2.39
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $13.86 · call volume: 110 · put volume: 7
Expected Move to 2026-12-18:
±$2.56
(18.51%) —
implied range
$11.29 –
$16.42
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | $1.05B | $31.43 | — |
| SIBN | SI-BONE, Inc. | $1.04B | $23.16 | — |
| ATEC | Alphatec Holdings, Inc. | $1.06B | $6.94 | — |
| IRMD | IRADIMED CORP | $1.07B | $83.45 | — |
| CBLL | Ceribell, Inc. | $1.01B | $25.97 | — |
News headlines (Yahoo Finance, 1h cache)
Integra LifeSciences (IART) Stock Could Be A Bargain Based On Cash Flow
2026-11-06 22:16 · Yahoo
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
2026-11-06 13:00 · Yahoo
Integra LifeSciences Holdings (IART) Could Be 41% Undervalued On Third Quarter Profit Turnaround
2026-11-03 01:24 · Yahoo
Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
2026-10-30 12:30 · Yahoo
3 value stocks we find risky
2026-10-26 20:30 · Yahoo
Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions
2026-10-24 11:16 · Yahoo
IART Q3 deep dive: Cincinnati disruption and Tissue Reconstruction challenges weigh on outlook
2026-10-22 08:46 · Yahoo
Why Integra LifeSciences (IART) stock is falling today
2026-10-21 21:26 · Yahoo
Integra: 3 Key Takeaways for Long-Term Investors
2026-10-21 18:11 · Yahoo
Integra (IART) Q3 2026 Earnings Call Transcript
2026-10-21 17:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.